A gene-editing drug developed by CRISPR Therapeutics and Vertex Pharma has achieved “remarkable” improvements in patients with beta thalassaemia and sickle cell disease in an early-stage trial ...

CTX classifies developer queries into four trigger types and routes each to a specialized retrieval pipeline. For dependency-sensitive queries, CTX traverses the codebase import graph to resolve ...

Carol M. Kopp edits features on a wide range of subjects for Investopedia, including investing, personal finance, retirement planning, taxes, business management, and career development. Investopedia ...

ctx watches what you are building, walks a 102,928-node graph, and recommends a small, top-scored bundle of skills, agents, and MCP servers for the current task. If you use your own local/API model ...

New lightweight self-retracting lifelines combine fall arrest and built-in retrieval capability. Confined spaces such as tanks, vaults, and tunnels present unique safety challenges where rapid rescue ...

New lightweight safety harness uses titanium hardware and advanced ventilation to improve worker comfort, mobility, and performance. LOS ANGELES, March 11, 2026 /PRNewswire/ -- FallTech has introduced ...

Centauri Therapeutics Ltd. has extended its series A financing round to £30 million (US$40.5 million) with the addition of a new £6 million (US$8 million) investment. Centauri initially closed its £24 ...

CTx001, a gene therapy for geographic atrophy, received FDA Fast Track Designation, expediting its development and review process. The Opti-GAIN phase 1/2 trial will assess CTx001's safety, ...

Abstract: Learned Image Compression (LIC) has achieved superior performance in recent years, of which the context entropy model is an important component. However, in the context entropy model, there ...

CTX is the governance token powering Cryptex Finance and its decentralized index products. Its utility goes beyond voting, influencing protocol decisions, risk parameters, and product development.

Once-daily formulation of dexmethylphenidate achieved primary endpoint (p < 0.001) with consistent symptom relief up to 12 hours post-dose KANSAS CITY, Kan., Oct. 28, 2025 (GLOBE NEWSWIRE) -- ...